Infarction, Middle Cerebral Artery clinical trials
The registry lists 40 studies for Infarction, Middle Cerebral Artery across more than 10 countries. 6 are recruiting or about to start. 24 of them are mainly about Infarction, Middle Cerebral Artery (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Infarction, Middle Cerebral Artery studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
China Medical University Hospital (3) · Xuanwu Hospital, Beijing (2) · Beijing Tiantan Hospital (1) · University of Minnesota (1) · Hospital of the Restoration, Recife (1) · University of Zurich (1) · Qianfoshan Hospital (1) · The University of Hong Kong (1)
What is being tested here
Drugs under test in Infarction, Middle Cerebral Artery studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Psilocybin | 1 | 0 | 1 |
| Tenecteplase | 0 | 1 | 1 |
| Deferoxamine | 0 | 0 | 1 |
| Epoetin Alfa | 0 | 1 | 1 |
| Basmisanil | 0 | 0 | 1 |
| Cenplacel-l | 0 | 0 | 1 |
| ONO2506 | 0 | 0 | 1 |
| Solizmestrocel | 0 | 0 | 1 |
| Levetiracetam | 0 | 0 | 1 |
| Perampanel | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke · Lahore University of Biological and Applied Sciences
- Jan 2027Integrated PET/MR Assessment of Brain Recovery After Recanalization of Non-Acute Atherosclerotic MCA Occlusion · Qianfoshan Hospital
- Feb 2027Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability · Johns Hopkins University
- Aug 2027Translational Immunodiagnostics in Stroke (TrImS) · The University of Hong Kong
Who these studies take
Of the 5 Infarction, Middle Cerebral Artery studies recruiting now, 1 (20%) set no upper age limit and 2 (40%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (20%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (80%) | 4 (80%) |
| 30 | 4 (80%) | 4 (80%) |
| 40 | 4 (80%) | 4 (80%) |
| 50 | 5 (100%) | 5 (100%) |
| 65 | 5 (100%) | 5 (100%) |
| 75 | 3 (60%) | 3 (60%) |
| 85 | 2 (40%) | 2 (40%) |
Across all 40 studies, recruiting or not: 33% stop at 75 or younger and 18% at 65; 5% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered2
Studies
Recruiting first, then most recently updated. Showing 40 of 40. search them.
- Integrated PET/MR Assessment of Brain Recovery After Recanalization of Non-Acute Atherosclerotic MCA OcclusionRecruitingNCT079275691 country
- Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery StrokeRecruitingNCT07902284Not applicable1 country
- Roods vs PNF for Upper Limb Function in Acute MCA StrokeEnrolling by invitationNCT07616622Not applicable1 country
- Translational Immunodiagnostics in Stroke (TrImS)RecruitingNCT053009971 country
- Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityRecruitingNCT07053917Phase 11 country
- Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 TrialRecruitingNCT05899582Not applicable1 country
- To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia Combined With Endovascular Reperfusion Therapy for Patients With Acute Anterior Circulation Large Artery OcclusionCompletedNCT06758609Not applicable1 country
- Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery OcclusionCompletedNCT06221371Phase 31 country
- Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction PatientsStatus unknownNCT04093336Phase 1/21 country
- Testing of Identification Markers for StrokeCompletedNCT042926001 country
- Thrombolysis and Deferoxamine in Middle Cerebral Artery OcclusionCompletedNCT00777140Phase 21 country
- HD-tDCs to Improve Upper Extremity Function in Patients With Acute Middle Cerebral Artery StrokeWithdrawnNCT04000269Not applicable
- The Carotid and Middle Cerebral Artery Occlusion Surgery StudyCompletedNCT01758614Phase 31 country
- Post-stroke Epilepsy: Primary Prophylaxis StudyStatus unknownNCT04858841Not applicable1 country
- Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic StrokeCompletedNCT01468064Phase 1/21 country
- An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in VietnamCompletedNCT036793641 country
- Osmotic Agent Use in Middle Cerebral Artery StrokeCompletedNCT041564901 country
- Autologous Bone Marrow Stem Cells in Ischemic Stroke.CompletedNCT00535197Phase 1/21 country
- Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) TrialSuspendedNCT03098732Not applicable1 country
- A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic StrokeTerminatedNCT02928393Phase 22 countries
- Dual-Task Training With Different Priority Instructional Sets on the Gait Parameters in Patients With Chronic StrokeCompletedNCT03752788Not applicable1 country
- Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral ArteryTerminatedNCT02609256Not applicable1 country
- Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic StrokeTerminatedNCT01310114Phase 21 country
- Intracranial Pressure After Decompressive CraniectomyCompletedNCT03364634
- tDCS in Acute Stroke PatientsStatus unknownNCT02806856Not applicable1 country
- Intraarterial Stem Cells in Subacute Ischemic StrokeCompletedNCT03080571Phase 1
- A Comparison Between Two Techniques for Performing Decompressive CraniectomyCompletedNCT02594137Not applicable
- The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)TerminatedNCT00401310Phase 2
- Stem Cell Therapy For Acute Ischemic Stroke PatientsCompletedNCT02425670Phase 21 country
- Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery InfarctStatus unknownNCT01461720Phase 21 country
- Thrombectomy Under Reopro Versus Alteplase to Treat StokeTerminatedNCT02016547Phase 41 country
- Impact of Cranioplasty On Cerebral PerfusionCompletedNCT011136451 country
- Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic StrokeStatus unknownNCT01438593Phase 11 country
- Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.CompletedNCT00761982Phase 1/21 country
- Implantation of Olfactory Ensheathing Cells (OECs)Status unknownNCT01327768Phase 11 country
- Study of Autologous Stem Cell Transplantation for Patients With Ischemic StrokeCompletedNCT00473057Phase 11 country
- Efficacy Study of CD34 Stem Cell in Chronic Stroke PatientsCompletedNCT00950521Phase 21 country
- Gait Training for Persons With StrokeCompletedNCT00612300Early Phase 11 country
- Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic StrokeCompletedNCT00604630Phase 2/31 country
- Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery OcclusionStatus unknownNCT00336596Phase 31 country